Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention.
Saved in:
| Title: | Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention. |
|---|---|
| Authors: | Koelmeyer LA; Australian Lymphoedema Education, Research, and Treatment (ALERT) Program, Faculty Medicine, Health & Human Sciences, Macquarie University, Sydney, New South Wales, Australia., Gaitatzis K; Australian Lymphoedema Education, Research, and Treatment (ALERT) Program, Faculty Medicine, Health & Human Sciences, Macquarie University, Sydney, New South Wales, Australia., Dietrich MS; Vanderbilt University School of Nursing, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Shah CS; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Boyages J; Australian Lymphoedema Education, Research, and Treatment (ALERT) Program, Faculty Medicine, Health & Human Sciences, Macquarie University, Sydney, New South Wales, Australia.; Icon Cancer Centre, Sydney, New South Wales, Australia., McLaughlin SA; Mayo Clinic, Jacksonville, Florida, USA., Taback B; Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA., Stolldorf DP; Vanderbilt University School of Nursing, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Elder E; Westmead Breast Cancer Institute, Westmead, New South Wales, Australia.; The University of Sydney, Sydney, New South Wales, Australia.; Lakeside Specialist Breast Clinic, Norwest, New South Wales, Australia., Hughes TM; ANU Clinical School at Sydney Adventist Hospital, Australian National University, Canberra, Australia., French JR; Westmead Breast Cancer Institute, Westmead, New South Wales, Australia.; The University of Sydney, Sydney, New South Wales, Australia.; Lakeside Specialist Breast Clinic, Norwest, New South Wales, Australia., Ngui N; Northern Surgical Oncology, Sydney Adventist Hospital, Wahroonga, New South Wales, Australia., Hsu JM; Westmead Breast Cancer Institute, Westmead, New South Wales, Australia.; Lakeside Specialist Breast Clinic, Norwest, New South Wales, Australia.; Macquarie University, Macquarie, Park, New South Wales, Australia., Moore A; Southeast Cancer Center, Cape Girardeau, Missouri, USA., Ridner SH; Vanderbilt University School of Nursing, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. |
| Source: | Cancer [Cancer] 2022 Sep 15; Vol. 128 (18), pp. 3408-3415. Date of Electronic Publication: 2022 Jul 07. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
